Tight junction protein changes in irritable bowel syndrome: the relation of age and disease severity
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The etiology of irritable bowel syndrome (IBS) is associated with intestinal mucosal barrier damage. However, changes in the tight junction (TJ) proteins in IBS have not been fully elucidated. This study aimed to evaluate TJ protein changes in IBS patients and the relationship between aging and disease severity. Methods: Thirty-six patients with IBS fulfilling the Rome IV criteria and twenty-four controls were included. To evaluate the change of TJ in the colonic mucosa, quantitative reverse transcription polymerase chain reaction, western blot, and immunohistochemistry (IHC) were performed, respectively. Results: The entire IBS group (n = 36) exhibited decreased levels of claudin-1 and -2 mRNA compared to the control group (n = 24), with statistical significance (p < 0.05). Additionally, in western blot analyses, both claudin-1 and ZO-1 levels were significantly reduced in the IBS group compared to the control group (n = 24) (p < 0.05). IHC analysis further revealed that ZO-1 expression was significantly lower in the IBS group than in the control group (p < 0.001). This trend of reduced ZO-1 expression was also observed in the moderate-to-severe IBS subgroup (p < 0.001). Significantly, ZO-1 expression was notably lower in both the young- (p = 0.036) and old-aged (p = 0.039) IBS groups compared to their respective age-matched control groups. Subtype analysis indicated a more pronounced decrease in ZO-1 expression with advancing age. Conclusions: ZO-1 expression was especially decreased in the aged IBS group. These results suggest that ZO-1 might be the prominent TJ protein causing IBS in the aging population.
Abstract
Background/Aims: The etiology of irritable bowel syndrome (IBS) is associated with intestinal mucosal barrier damage. However, changes in the tight junction (TJ) proteins in IBS have not been fully elucidated. This study aimed to evaluate TJ protein changes in IBS patients and the relationship between aging and disease severity. Methods: Thirty-six patients with IBS fulfilling the Rome IV criteria and twenty-four controls were included. To evaluate the change of TJ in the colonic mucosa, quantitative reverse transcription polymerase chain reaction, western blot, and immunohistochemistry (IHC) were performed, respectively. Results: The entire IBS group (n = 36) exhibited decreased levels of claudin-1 and -2 mRNA compared to the control group (n = 24), with statistical significance (p < 0.05). Additionally, in western blot analyses, both claudin-1 and ZO-1 levels were significantly reduced in the IBS group compared to the control group (n = 24) (p < 0.05). IHC analysis further revealed that ZO-1 expression was significantly lower in the IBS group than in the control group (p < 0.001). This trend of reduced ZO-1 expression was also observed in the moderate-to-severe IBS subgroup (p < 0.001). Significantly, ZO-1 expression was notably lower in both the young- (p = 0.036) and old-aged (p = 0.039) IBS groups compared to their respective age-matched control groups. Subtype analysis indicated a more pronounced decrease in ZO-1 expression with advancing age. Conclusions: ZO-1 expression was especially decreased in the aged IBS group. These results suggest that ZO-1 might be the prominent TJ protein causing IBS in the aging population.
참고문헌 (33)
- Enck P, "Irritable bowel syndrome", Nat Rev Dis Primers, 2, pp.16014~ (2016)
- Canavan C, "The epidemiology of irritable bowel syndrome", Clin Epidemiol, 6, pp.71~80 (2014)
- Chey WD, "Irritable bowel syndrome : a clinical review", JAMA, 313, pp.949~958 (2015)
- Canavan C, "Review article : the economic impact of the irritable bowel syndrome", Aliment Pharmacol Ther, 40, pp.1023~1034 (2014)
- Drossman DA, "AGA technical review on irritable bowel syndrome", Gastroenterology, 123, pp.2108~2131 (2002)
- Moshiree B, "Clinical and basic neurogastroenterology and motility" (2020), Academic Press
- Peterson LW, "Intestinal epithelial cells : regulators of barrier function and immune homeostasis", Nat Rev Immunol, 14, pp.141~153 (2014)
- Anderson JM, "Tight junctions and the molecular basis for regulation of paracellular permeability", Am J Physiol, 269(4 Pt 1), pp.G467~G475 (1995)
- Greene C, "Claudin-5 : gatekeeper of neurological function", Fluids Barriers CNS, 16, pp.3~ (2019)
- Lee SH, "Intestinal permeability regulation by tight junction : implication on inflammatory bowel diseases", Intest Res, 13, pp.11~18 (2015)
- Arrieta MC, "Alterations in intestinal permeability", Gut, 55, pp.1512~1520 (2006)
- Horowitz A, "Paracellular permeability and tight junction regulation in gut health and disease", Nat Rev Gastroenterol Hepatol, 20, pp.417~432 (2023)
- McCarthy KM, "Occludin is a functional component of the tight junction", J Cell Sci, 109(Pt 9), pp.2287~2298 (1996)
- Inai T, "Claudin-1 contributes to the epithelial barrier function in MDCK cells", Eur J Cell Biol, 78, pp.849~855 (1999)
- Fanning AS, "Zonula occludens-1 and-2 are cytosolic scaffolds that regulate the assembly of cellular junctions", Ann N Y Acad Sci, 1165, pp.113~120 (2009)
- Piche T, "Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome : involvement of soluble mediators", Gut, 58, pp.196~201 (2009)
- Zeeshan MH, "Irritable bowel syndrome in adults : prevalence and risk factors", Ann Med Surg(Lond), 81, pp.104408~ (2022)
- Drossman DA, "Functional gastrointestinal disorders : history, pathophysiology, clinical features and Rome IV", Gastroenterology, 150, pp.1262~1279 (2016)
- Francis CY, "The irritable bowel severity scoring system : a simple method of monitoring irritable bowel syndrome and its progress", Aliment Pharmacol Ther, 11, pp.395~402 (1997)
- Bertiaux-Vandaële N, "The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype", Am J Gastroenterol, 106, pp.2165~2173 (2011)
- Böhn L, "Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life", Am J Gastroenterol, 108, pp.634~641 (2013)
- Hanning N, "Intestinal barrier dysfunction in irritable bowel syndrome : a systematic review", Therap Adv Gastroenterol, 14, pp.1756284821993586~ (2021)
- Cheng P, "Molecular and cellular mechanisms of tight junction dysfunction in the irritable bowel syndrome", Mol Med Rep, 12, pp.3257~3264 (2015)
- Tsai PY, "IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance", Cell Host Microbe, 21, pp.671~681 (2017)
- Weber CR, "Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity", J Biol Chem, 285, pp.12037~12046 (2010)
- Marchiando AM, "Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo", J Cell Biol, 189, pp.111~126 (2010)
- Coëffier M, "Increased proteasome-mediated degradation of occludin in irritable bowel syndrome", Am J Gastroenterol, 105, pp.1181~1188 (2010)
- Zeng J, "Clinical trial : effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome", Aliment Pharmacol Ther, 28, pp.994~1002 (2008)
- Camilleri M, "Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion", Am J Physiol Gastrointest Liver Physiol, 309, pp.G10~G20 (2015)
- Zhen Y, "Imbalance of tumor necrosis factor-α, interleukin-8 and interleukin-10 production evokes barrier dysfunction, severe abdominal symptoms and psychological disorders in patients with irritable bowel syndrome-associated diarrhea", Mol Med Rep, 12, pp.5239~5245 (2015)
- Ishimoto H, "Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients", J Clin Biochem Nutr, 60, pp.146~150 (2017)
- Camilleri M, "RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea : a pilot case-control study", Am J Physiol Gastrointest Liver Physiol, 306, pp.G1089~G1098 (2014)
- Piche T, "Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?", Neurogastroenterol Motil, 26, pp.296~302 (2014)